Gene therapy of liver diseases
- 1 July 2004
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Biological Therapy
- Vol. 4 (7) , 1073-1091
- https://doi.org/10.1517/14712598.4.7.1073
Abstract
Many liver diseases lack satisfactory treatment and alternative therapeutic options are urgently needed. Gene therapy is a new mode of treatment for both inherited and acquired diseases, based on the transfer of genetic material to the tissues. Genes are incorporated into appropriate vectors in order to facilitate their entrance and function inside the target cells. Gene therapy vectors can be constructed on the basis of viral or non-viral molecular structures. Viral vectors are frequently used, due to their higher transduction efficiency. Both the type of vector and the expression cassette determine the duration, specificity and inducibility of gene expression. A considerable number of preclinical studies indicate that a great variety of liver diseases, including inherited metabolic defects, chronic viral hepatitis, liver cirrhosis and primary and metastatic liver cancer, are amenable to gene therapy. Gene transfer to the liver can also be used to convert this organ into a factory of secreted proteins ne...Keywords
This publication has 200 references indexed in Scilit:
- Cytokines in cancer pathogenesis and cancer therapyNature Reviews Cancer, 2004
- Bacterial virus phi29 pRNA as a hammerhead ribozyme escort to destroy hepatitis B virusGene Therapy, 2003
- Progress and problems with the use of viral vectors for gene therapyNature Reviews Genetics, 2003
- Modified apoptotic molecule (BID) reduces hepatitis C virus infection in mice with chimeric human liversNature Biotechnology, 2003
- Site-specific genomic integration produces therapeutic Factor IX levels in miceNature Biotechnology, 2002
- Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectorsGene Therapy, 2001
- Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the escherichia coli purine nucleoside phosphorylase geneHepatology, 2000
- Core specific antisense phosphorothioate oligodeoxynucleotides as potent and specific inhibitors of hepatitis C viral translationArchiv für die gesamte Virusforschung, 1997
- In VivoInhibition of Hepatitis B Virus Gene Expression by Antisense Phosphorothioate OligonucleotidesBiochemical and Biophysical Research Communications, 1996
- Costimulation of T cells for tumor immunityImmunology Today, 1993